TELA Bio Inc (TELA)
5.98
-0.14
(-2.29%)
USD |
NASDAQ |
May 22, 16:00
5.98
0.00 (0.00%)
After-Hours: 20:00
TELA Bio Research and Development Expense (Quarterly): 2.393M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.393M |
| December 31, 2023 | 2.685M |
| September 30, 2023 | 2.368M |
| June 30, 2023 | 2.514M |
| March 31, 2023 | 2.052M |
| December 31, 2022 | 2.726M |
| September 30, 2022 | 2.102M |
| June 30, 2022 | 2.102M |
| March 31, 2022 | 2.007M |
| December 31, 2021 | 1.725M |
| September 30, 2021 | 1.409M |
| June 30, 2021 | 1.93M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.679M |
| December 31, 2020 | 1.163M |
| September 30, 2020 | 1.201M |
| June 30, 2020 | 0.979M |
| March 31, 2020 | 0.912M |
| December 31, 2019 | 0.921M |
| September 30, 2019 | 0.516M |
| June 30, 2019 | 1.055M |
| March 31, 2019 | 1.659M |
| December 31, 2018 | 0.977M |
| September 30, 2018 | 1.044M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.516M
Minimum
Sep 2019
2.726M
Maximum
Dec 2022
1.722M
Average
1.828M
Median
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 5.001M |
| Dynatronics Corp | -- |
| Stereotaxis Inc | 2.243M |
| Electromed Inc | 0.167M |
| Myomo Inc | 0.9562M |